Vbi Vaccines Inc CS (VBIV)

$0.99 0.02 (2.43%)

16:00 EDT VBIV Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Dec 7, 2021

Good morning, trader! We're beginning another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!

VBIV Stock Is Shooting Higher on Big FDA Vaccine Approval News

7 Penny Stocks Waiting on the FDA for Rocket Fuel

8 Biotech Penny Stocks for Investors to Watch

Volume:

Previous Close -

Market Cap 256.63M

PE Ratio -4.97

EPS -0.2

Volume (Avg. Vol.) 1.86M

Day's Range $0.90 - $1.00

52-Week Range $0.95 - $4.31

Dividend & Yield N/A (N/A)

VBIV Stock Predictions, Articles, and Vbi Vaccines Inc CS News

From InvestorPlace

8 Penny Stocks to Avoid in 2021

By Thomas Niel Jan 11, 2021

With risk-return not in your favor, steer clear of these 8 penny stocks, all of which could see big declines as the new year unfolds. Chesapeake Energy (OTCMKTS:CHKAQ) Genius Brands (NASDAQ:GNUS) Hertz Global Holdings (OTCMKTS:HTZGQ) Remark Holdings (NASDAQ:MARK) Ocugen (NASDAQ:OCGN) StoneMor (NYSE:STON) VBI Vaccines (NASDAQ:VBIV) XspresSpa (NASDAQ:XSPA)

7 Short-Term Stocks to Make a Quick Buck

By Josh Enomoto, InvestorPlace Contributor Oct 16, 2020

It wasn’t just toilet paper that was in demand when Covid-19 hit us as short-term stocks flew through the roof. But with a second wave upon us, this narrative looks very compelling.

While Risks Remain, VBI Vaccines Stock Is a Buy at Today’s Prices

By Thomas Niel Feb 5, 2020

Sci-B-Vac's success will make or break VBIV stock. But the shares' recent pullback may have created a great buying opportunity.

5 Stocks Under $5 With Colossal Growth Prospects

By Maya Sasson, Writer, TipRanks Jan 31, 2020

While some argue you get what you pay for, others say that stocks trading at low levels can represent compelling opportunities.

Is It Time to Go Long on VBIV Stock?

By Chris Markoch Jan 30, 2020

As a speculative pharmaceutical investment, VBIV stock is not for the faint of heart. However, the underlying business suggests some rationale for longer-term optimism.

VBI Vaccines News: VBIV Stock Skyrockets 17% on Clinical Trial Success

By William White, InvestorPlace Writer Jan 13, 2020

VBI Vaccines (VBIV) news for Monday about results from a recent clinical trial of a hepatitis B vaccine have VBI stock soaring.

5 Stocks to Buy Based on Insider Buying

By Mark Putrino, CMT Oct 8, 2019

These are five stocks to consider buying because of significant insider buying activity. Insiders only buy for one reason: to make money.

3 Pivotal Drug Trials to Watch for Explosive Potential

By Samuel Rae, InvestorPlace Contributor Jun 29, 2017

Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon.

Vbi Vaccines Inc CS (VBIV)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

VBIV Stock Is Shooting Higher on Big FDA Vaccine Approval News

7 Penny Stocks Waiting on the FDA for Rocket Fuel

8 Biotech Penny Stocks for Investors to Watch

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Vbi Vaccines Inc CS (VBIV)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

VBIV Stock Predictions, Articles, and Vbi Vaccines Inc CS News

Subscriber Sign in